Literature DB >> 28760590

Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.

Sh Banaeian1, M Sereshti2, M Rafieian3, F Farahbod4, S Kheiri5.   

Abstract

BACKGROUND AND
OBJECTIVE: Vulvovaginal candidiasis (VVC) is the most prevalent vaginitis in women, accounting for 10 million medical referrals a year. Vaginal clotrimazole is a drug of choice for VVC treatment. However, increased drug resistance to this microorganism has led to an interest in naturally derived antifungal drugs. This study was conducted to compare honey vaginal ointment and clotrimazole vaginal ointment for VVC treatment.
METHODS: Eighty women diagnosed with VVC were assigned to two groups for honey ointment and clotrimazole ointment treatment using a simple randomization rule. The ointments were applied at night for seven days. The disease symptoms including inflammation, vaginal discharge, and irritation at baseline in the fourth and eighth days of treatment were examined and compared between the two groups. The data was analyzed by SPSS version 20 with the Friedman test, Chi-square test, and independent t-test. P<0.05 was considered as the significance.
RESULTS: The two groups were similar for inflammation severity, irritation, and discharge at baseline. In both the groups, the symptoms disappeared after treatment. On the eighth day of treatment, there was a significant difference in inflammation and vaginal discharge between the two groups. Inflammation (P=0.002) and vaginal discharge (P=0.003) recovered better in the clotrimazole group. But there was no significant difference in irritation severity and satisfaction with treatment between the two groups. In the two groups, no side effects were reported.
CONCLUSION: Honey contributes to treating VVC. Thanks to the popular positive attitudes of honey, its availability, no need for sterility, and its cost-effectiveness, it is a choice of treatment for VVC.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Candida albicans; Clotrimazole; Honey; Vaginitis

Mesh:

Substances:

Year:  2017        PMID: 28760590     DOI: 10.1016/j.mycmed.2017.07.003

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  4 in total

1.  Chlorhexidine, clotrimazole, metronidazole and combination therapy in the treatment of vaginal infections.

Authors:  Shahla Mirzaeei; Maryam Zangeneh; Firoozeh Veisi; Somayeh Parsa; Maryam Hematti
Journal:  J Med Life       Date:  2021 Mar-Apr

2.  Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?

Authors:  Yayoi Kawano; Olivier Jordan; Takehisa Hanawa; Gerrit Borchard; Viorica Patrulea
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-05-19       Impact factor: 4.730

3.  Augmentation of the Female Reproductive System Using Honey: A Mini Systematic Review.

Authors:  Nur Hilwani Ismail; Siti Fatimah Ibrahim; Farah Hanan Fathihah Jaffar; Mohd Helmy Mokhtar; Kok Yong Chin; Khairul Osman
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

4.  Bioactive triterpenoids from Solanum torvum fruits with antifungal, resistance modulatory and anti-biofilm formation activities against fluconazole-resistant candida albicans strains.

Authors:  Benjamin Kingsley Harley; David Neglo; Philip Tawiah; Mercy Adansi Pipim; Nana Ama Mireku-Gyimah; Clement Okraku Tettey; Cedric Dzidzor Amengor; Theophilus Christian Fleischer; Sayanika Devi Waikhom
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.